Conference Calendar
Alzheimer's Association International Conference 2018
– DOWNLOAD TO YOUR CALENDAR
Chicago, Illinois
View Conference Website
Past AlzForum Coverage:
- Alzheimer's Association International Conference 2013
- Cerebrospinal Fluid Tau Climbs in Aβ Mouse Models
- Coverage Denial For Amyloid Scans Riles Alzheimer’s Community
- Pooled GWAS Reveals New Alzheimer’s Genes and Pathways
- Are Subtle Memory Concerns a Sign of Future Dementia?
- Clinical Trials Roundup: Four Hits, No Home Runs
- Clinical Trials Roundup: Broadening the Lines of Attack
- Curbing Innate Immunity Boosts Synapses, Cognition
- Scientists Hunting Rare Alzheimer’s Mutations Eye Phospholipase D3
- Biomarkers Predict Alzheimer’s, But Shoe Does Not Always Fit
- Suspected Non-Amyloid Pathology (SNAP)—Not an Open or Shut Case
- Dementia Prevalence Falls in England
- Are Protein Strains The Cause of Different Tauopathies?
- Tau Tracers Shine at Boston Conference
- Tales of Traveling Tau: Is Transfer Between Neurons Normal?
- Alzheimer's Association International Conference 2012
- Experimental α7 Agonist Meets Cognitive and Clinical Endpoints
- New Assays for Aβ Oligomers in CSF Claim Femtogram Sensitivity
- Q&A With Roche’s CNS Leader Luca Santarelli
- When Is a C9ORF72 Repeat Expansion Not a C9ORF72 Repeat Expansion?
- Wave of New BACE Inhibitors Heading to Phase 2
- Researchers Join to Draw Posterior Cortical Atrophy Out of Shadows
- Cochrane Asks for Field’s Input on Draft Reporting Standards
- Can We All Agree on How to Draw a Hippo(campus)?
- Collaborative Umbrella CAPs Three Prevention Trial Initiatives
- On Risk, Benefit, and More, Prevention Initiatives Take Questions
- In Big Picture, Familial AD’s Biomarker Data Resemble LOAD
- Dimmed Network Connections May Explain Metabolic Shortfall
- To Reveal or Not to Reveal? New Data on the Question
- iPSC Disease Models Up and Coming for AD, Down’s, ALS
- GWAS Mega-Meta Yields More Risk Genes, BIN1 Binds Tau?
- Night Owl? Early Bird? Good Night’s Sleep May Protect the Brain
- Plaque May Quash Seesawing CSF Aβ Levels
- Could Sortilin Be a Sweet Spot for FTD Therapy?
- Alzheimer's Association International Conference on Alzheimer's Disease 2011
- Paris: Renamed ARIA, Vasogenic Edema Common to Anti-Amyloid Therapy
- Paris: Semagacestat Autopsy and Other News of Trial Tribulations
- Paris: More Trial News, Mixed at Best
- Paris: President and All, French Science Takes the Stage
- Paris: Beyond Genomics, French Science Draws on Populations, Patients
- Paris: Studies Strengthen Link Between Brain Injury and Dementia
- Paris: Standardization a Hurdle for Spinal Fluid, Imaging Markers
- Alzheimer's Association International Conference on Alzheimer's Disease 2010
- Honolulu: FDA Approval in Sight for 18F Amyloid Tracer Florbetapir?
- Honolulu: Tomm40 Reported to Track With Brain Atrophy, Cognition
- Honolulu: TrialMatch Launched as AD Is Becoming “Desktop” Disease
- Honolulu: The Missing Link? Tau Mediates Aβ Toxicity at Synapse
- Honolulu: Wake-Up Call—Aβ Clearance, Not Production, Awry in AD
- Honolulu: Intranasal Insulin Trial Claims Promise in MCI, AD
- Honolulu: TDP-43 Gets a Place in the Sun
- Honolulu: Neuroregeneration Taps Glia, Neurotrophins
- Noisy Response Greets Revised Diagnostic Criteria for AD
- Revised Criteria for Preclinical AD, Exactly as Presented
- What Do Clinicians Say? Peers Welcome Revised Criteria
- Honolulu: Monkey, Rat Join Menagerie of Mammalian AD Models
- Honolulu: Biomarker Profiles That Spell Trouble for ‘Normals’?
- International Conference on Alzheimer's Disease 2009
- Vienna: New Genes, Anyone? ICAD Saves Best for Last
- Vienna: In Genetics, Bigger Is Better—Data Sharing Nets Three New Hits
- Vienna: Can a D-Peptide Turn Tiger Into Pussycat?
- Vienna: New Shoot Among Ashes of Drug Trials
- Vienna: New Tack to See Amyloid Oligomers in Body Fluids
- Vienna (and Burkina Faso): What's New With Methylene Blue?
- International Conference on Alzheimer's Disease 2008
- Chicago: Studies Probe Diminishing Placebo Decline, Part 1
- Chicago: Studies Probe Diminishing Placebo Decline, Part 2
- Chicago: ICAD Offered Mix Bag of Setbacks and Hopeful News
- Chicago: Trial Design Bedevils Search for New AD Drugs, Part 1
- Chicago: The Phase 2 Problem and the Way to a Surrogate, Part 2
- Chicago: Out of the Blue—A Tau-based Treatment for AD?
- Chicago: Dimebon Safe for 18 Months
- Chicago: Bapineuzumab’s Phase 2—Was the Data Better Than the Spin?
- Chicago: Lilly’s Antibody Appears to Do No Harm, But Will It Help?
- Chicago: APP Roles in Caspase Gene Regulation, Muscle Function?
- Chicago: Flurizan Postmortem
- Chicago: Translational and Basic Science of Tau Advances
- Chicago: Brain-Penetrant Microtubule Stabilizer in Tauopathy Mice
- Chicago: Tau Projection Domain May Block Excitotoxicity in Mice
- Chicago: Does Saying “I Do” Lower Late-life Dementia Risk?
- Chicago: More News From Phase 2s
- Chicago: More Phase 2 News—PBT2 and IVIg
- Chicago: Phase 2 News—Therapeutic Breakfast Food?
- Alzheimer's Association International Conference 2007
- Washington: Alzhemed Non-story Yields Spotlight to Phase 2 Treatments
- Washington: Shaking Up AD Treatment with Ketone Bodies
- Washington: Site-to-Site Differences Delay Result of Alzhemed Trial
- Washington: γ-secretase Inhibitor Survived Phase 2, Moving to 3
- Washington: Functional Improvement From Stopped Vaccine
- International Conference on Alzheimer's Disease 2004
- Philadelphia: All Eyes on PIB Imaging—Is It Coming Along?
- Philadelphia: All Is Not Well with the Statin Story
- Philadelphia: Can a Shrinking Brain Be Good for You?
- Philadelphia: Dementia Types Just Won’t Fit into Little Boxes
- Philadelphia: Diagnosis Light—Toward Infrared Plaques
- Philadelphia: European Trial of Alzhemed Ends, Marketing Morphs to Supplement
- Philadelphia: Mom Was Right. Eat Your Carrots!
- Philadelphia: Targets in a Barely Tapped Market Keep Big Pharma Focused on AD
- Philadelphia: The Enemy Within—Neurodegeneration From Intraneuronal Aβ
- International Conference on Alzheimer's Disease 2002
- Stockholm: Visualizing Amyloid Biggest Draw at Imaging Symposium, Consensus Sought on Validation
- Stockholm: Chlamydia Triggers Amyloid Plaques in Mice
- Stockholm: Aph-1 and Pen-2: New Names in the Presenilin Debate Complete the Complex?
- Stockholm: Clusterin (or Beware the Evil Chaperone!)
- Stockholm: Gold in Them Thar Hills?
- Stockholm: Not All NSAIDs Are Equally Good When it Comes to Alzheimer’s
- Stockholm: Separating Good from Bad Inflammation in AD: Complement Steps into Limelight
- Stockholm: Larger Study Finds Protective Effect of Statin Use
- Stockholm: Liver Found to Degrade Aβ
- Stockholm: Bad News Official: The Rofecoxib and Naproxen Clinical Trial Has Failed
- Stockholm: Presenting α-T Catenin: A Long-Awaited Gene on Chromosome 10?
- Stockholm: Educated Guessing Game: Which Genes Does “Other” APP Snippet Regulate?
- Stockholm: Could a Whiff of NAP Nip Brain Inflammation in the Bud?
- Stockholm: There Is No Spatial Paradox!
- Stockholm: The Presenilin Signaling Hub—A RIP-off or the Real Deal?
- Stockholm: Degradation on the Rise
- Stockholm: Core Resistance
- Stockholm: Pictures at an Exhibition
- International Conference on Alzheimer's Disease 1998
- Sixth Int. Conference on AD: Mechanisms of Neurodegenerative Conditions I
- Sixth Int. Conference on AD: Genetics I
- Sixth Int. Conference on AD: Monkey Brain Injections
- Sixth Int. Conference on AD: Cellular/Animal Models I
- Sixth Int. Conference on AD: Mechanisms of Neurodegenerative Conditions II
- Sixth Int. Conference on AD: Towards the Next Generation of AD Therapeutics
- Sixth Int. Conference on AD: Mahley Plenary Lecture
- Sixth Int. Conference on AD: Mechanisms of Neurodegerative Conditions III
- Sixth Int. Conference on AD: Pathology I
- Sixth Int. Conference on AD: Molecular Interactions in AD Pathogenesis
- Sixth Int. Conference on AD: Development of Aβ Peptide Inhibitors
- Sixth Int. Conference on AD: Roundtable C: Metabolism and Alzheimer's
- Sixth Int. Conference on AD: Satellite Symposium on AD7c-NTP
- Sixth Int. Conference on AD: Aging Astrocytes: A Role in AD?
- Sixth Int. Conference on AD: Fibril-busting Mystery Herb
- Sixth Int. Conference on AD: Presenilin-binding Proteins Abound
- Sixth Int. Conference on AD: Search for Late-Onset AD Genes
- Sixth Int. Conference on AD: Scientists Smitten by Mad Tau Disease